Press releases
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
Key statistics
On Friday, Sarepta Therapeutics Inc (0L35:LSE) closed at 123.30, -13.77% below its 52-week high of 143.00, set on Feb 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 123.30 |
Average volume | 2.66k |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,502.70 |
Market cap | 11.32bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 20 minutes, as of Jun 07 2024 18:29 BST.
More ▼